Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on February 26, 2019. Details of which are enclosed.
26-02-2019
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sirs, In continuation to our letter dated February 15, 2019 please find enclosed copy of Postal Ballot Notice published in the Financial Express and Navshakti on February 16, 2019 intimating the Members about dispatch of Postal Ballot Notice, Postal Ballot Form and other required details. The same has been made available on the website of the Company www.novartis.in.
18-02-2019
Bigul

Novartis India Ltd - 500672 - Loss of Share Certificate / Issue of Duplicate Share Certificate

Novartis India Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
18-02-2019
Bigul

Novartis India Ltd - 500672 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

This letter is in continuance to our letter dated February 04, 2019 informing you about the approval of the Board of Directors for re-appointment of Mr. Jai Hiremath (DIN: 00062203) and Dr. Rajendra Nath Mehrotra(DIN: 00172639) as Independent Directors of the Company, subject to shareholders approval. In this context, we hereby enclose a copy of Postal Ballot Notice & Postal Ballot Form being sent to the Shareholders of the Company, which are self explanatory. The Postal Ballot Notice seeks approval of Members through Special Resolution for re-appointment of Mr. Jai Hiremath (DIN: 00062203) and Dr. Rajendra Nath Mehrotra (DIN: 00172639) as Independent Directors of the Company for a term of five years and one year respectively, commencing from April 1, 2019. The Company has dispatched the Postal Ballot Notice along with the explanatory statement and Postal Ballot Form to all the Members whose names appear on the Register of Members/ List of Beneficial owners as on Friday, February 8, 2019, as received from National Securities Depository Limited ('NSDL') and Central Depository Services (India) Limited. The dispatch is completed today, February 15, 2019.
15-02-2019
Bigul

Novartis India Ltd - 500672 - Loss of Share Certificate / Issue of Duplicate Share Certificate

Novartis India Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
05-02-2019
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sirs, In continuation to our letter dated February 04, 2019 please find enclosed copies of Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2018 that was published in the Financial Express and Navshakti on February 05, 2019. The same has been made available on the website of the Company www.novartis.in. Thanking you Yours sincerely, For Novartis India Limited
05-02-2019
Bigul

Novartis India Q3 net dips 31%

Drug firm Novartis India on Monday reported a 31 per cent decline in net profit to 12.87 crore for the quarter ended December 2018. The company had
04-02-2019
Bigul

Novartis India Ltd - 500672 - Postal Ballot

Based on the recommendation of the Nomination and Remuneration Committee and approval of the Board and subject to the approval of the shareholders of the Company by Postal Ballot, Mr. Jai Hiremath and Dr. Rajendra Nath Mehrotra be re-appointed as Independent Directors of the Company for a term of five years and one year respectively, commencing from April 1, 2019. In terms of Sections 108 and 110 of the Companies Act, 2013, Rule 20 of the Companies (Management & Administration) Rules 2014, and applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company will provide its shareholders the facility to exercise their vote for transacting the item of special business via postal ballot and e-voting. For this purpose, the Company has fixed Friday, February 8, 2019 as the cut-off / specified date to record the entitlement of the shareholders to cast their vote through Postal Ballot / E-voting.
04-02-2019
Bigul

Novartis India Ltd - 500672 - Outcome of Board Meeting

Based on the recommendation of the Nomination and Remuneration Committee and approval of the Board and subject to the approval of the shareholders of the Company by Postal Ballot, Mr. Jai Hiremath (DIN: 00062203) and Dr. Rajendra Nath Mehrotra (DIN: 00172639) are re-appointed as Independent Directors of the Company for a term of five years and one year respectively, commencing from April 1, 2019. It is also informed that none of the Directors of the Company are related to Mr. Hiremath and Dr. Mehrotra. Mr. Hiremath holds no shares in the Company and Dr. Mehrotra holds 220 equity shares in the Company. The draft Postal Ballot Notice with respect to the re-appointment of Mr. Hiremath and Dr. Mehrotra was approved by the Board at its meeting held on February 4, 2019 and the Board authorized the Company Secretary to finalize the Postal Ballot Notice, explanatory statement and notes thereon and issue the same to the members of the Company.
04-02-2019
Bigul

Novartis India Ltd - 500672 - Results-Financial Results For The Quarter Ended December 31,2018

We refer to our letter dated December 31, 2018, informing you of our Board Meeting that was scheduled for today. The meeting of the Board of Directors of the Company commenced at 12.00 noon and concluded at 3.50 p.m. Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at this meeting approved the following: Financial results of the Company for the third quarter and nine months ended December 31, 2018. Copy of the financial results approved at this meeting along with the Limited Review Report provided by Deloitte Haskins & Sells LLP, Auditors of the Company is enclosed as Annexure 1. We have made arrangements for publishing an extract of the above mentioned financial results as per the format prescribed under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015, in the selected newspapers.
04-02-2019
Next Page
Close

Let's Open Free Demat Account